Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 22

Trial Status

Completed1
Recruiting1

Role Distribution

Principal Investigator1
Other Roles1
PI Rate50%

Activity Timeline

Clinical Trials (2)

NCT04099966Phase 2Recruiting
AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion
Acute LeukemiaAmegakaryocytic ThrombocytopeniaBeta-Thalassemia+6 more
StudychairStart date: 2021-04-01
NCT00529360Phase 1/2Completed
Allogeneic Stem Cell Transplant With Clofarabine, Ara-C and TBI for AML and ALL
Acute Lymphoblastic LeukemiaAcute Myelogenous Leukemia
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Related
24 trials

Shared therapeutic areas:

Acute LeukemiaLeukemia, Myeloid, AcuteAnemia, Sickle Cell+3 more
Similarity Score16%

Yves Beguin, MD, PhD

CHU-ULg

Related
7 trials

Shared therapeutic areas:

Hodgkin DiseasePrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myeloid, Acute+1 more
Similarity Score11%

Qifa Liu

Nanfang Hospital, Southern Medical University

Related
33 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteAcute LeukemiaPrecursor Cell Lymphoblastic Leukemia-Lymphoma
Similarity Score8%

Arnon Nagler, MD

Chaim Sheba Medical Center

Related
12 trials

Shared therapeutic areas:

Hodgkin DiseaseLymphoma, Non-HodgkinLeukemia, Myeloid, Acute
Similarity Score8%

Helen Heslop, MD

Baylor College of Medicine

Related
17 trials

Shared therapeutic areas:

Lymphoma, Non-HodgkinPrecursor Cell Lymphoblastic Leukemia-LymphomaHodgkin Disease
Similarity Score8%

David Avigan, MD

Beth Israel Deaconess Medical Center

Related
17 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteHodgkin DiseasePrecursor Cell Lymphoblastic Leukemia-Lymphoma

Worked with same sponsors:

Genzyme, a Sanofi Company
Similarity Score8%

John F Tisdale, M.D.

National Heart, Lung, and Blood Institute (NHLBI)

Related
17 trials

Shared therapeutic areas:

Anemia, Sickle Cellbeta-Thalassemia
Similarity Score5%

Brigitte C Widemann, M.D.

National Cancer Institute (NCI)

Related
19 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myeloid, Acute
Similarity Score5%

Jae Park, MD

Memorial Sloan Kettering Cancer Center

Related
17 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myeloid, Acute
Similarity Score5%

Jorge Cortes, MD

M.D. Anderson Cancer Center

Related
24 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcutePrecursor Cell Lymphoblastic Leukemia-Lymphoma
Similarity Score5%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT04099966Phase 2StudyChair

AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion

Acute LeukemiaAmegakaryocytic ThrombocytopeniaBeta-Thalassemia+6 more
Recruiting
NCT00529360Phase 1/2PrincipalInvestigator

Allogeneic Stem Cell Transplant With Clofarabine, Ara-C and TBI for AML and ALL

Acute Lymphoblastic LeukemiaAcute Myelogenous Leukemia
Completed

All 2 trials loaded